4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001780081-26-000002
Director sold 7,229 shares at $39.66 ($286,715)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krainer Adrian R. Director | 2026-03-02 | Sale 10b5-1 | −7,229 | $39.66 | $286,715 | 316,545 | D: show line 1 in the form |
| Open-market sales · 7,229 sh · avg $39.66 · $286,715 | |||||||
Loading xslF345X05/form4-03042026_090337.xml…